An outbreak of Burkholderia cenocepacia bacteremia in immunocompromised oncology patients
- 700 Downloads
Burkholderia cepacia is a common environmental bacterium that is resistant to disinfectants, and therefore is often encountered as a hospital-acquired pathogen. We describe an outbreak of B. cenocepacia bacteremia among hospitalized oncology patients.
A matched case–control study and an extensive environmental investigation were conducted. Species were identified by RFLP of the amplified recA gene. DNA was fingerprinted by pulsed-field gel electrophoresis (PFGE).
Between November 2005 and September 2006, B. cenocepacia bacteremia developed in 17 patients with underlying malignancy of whom 14 had tunneled central venous catheters. All patients had fever and chills which subsided following removal of the central catheter and administration of ceftazidime. Extensive epidemiological investigation could not find a common source for the outbreak. Patients were hospitalized in three different buildings with different health care personnel. Medications were prepared in different sites by different personnel. A multivariate analysis demonstrated that the independent risk factors for developing nosocomial B. cenocepacia bacteremia were hospitalization at the center for long-term support (OR 28.8; 95% CI 1.83–453.4) and reduced use of antibiotics during the last month (OR 0.07; 95% CI 0.01–0.40). All isolates had identical antimicrobial susceptibility; PFGE indicated that a complex of closely related strains was involved in the outbreak. All isolates were identified as B. cenocepacia, known to infect cystic fibrosis patients. Strict infection control measures terminated the outbreak.
B. cenocepacia is an emerging nosocomial pathogen among oncology patients.
KeywordsBurkholderia cenocepacia Immunocompromised patients Bacteremia
Conflict of interest statement
- 26.Mahenthiralingam E, Bischof J, Byrne SK, Radomski C, Davies JE, Av-Gay Y, et al. DNA-based diagnostic approaches for identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis, and Burkholderia cepacia genomovars I and III. J Clin Microbiol. 2000;38:3165–73.PubMedGoogle Scholar
- 30.Rhee JY, Kwon KT, Ki HK, Shin SY, Jung DS, Chung DR, et al. Scoring systems for prediction of mortality in patients with intensive care unit-acquired sepsis: a comparison of the Pitt bacteremia score and the Acute Physiology and Chronic Health Evaluation II scoring systems. Shock. 2009;31:146–50.CrossRefPubMedGoogle Scholar
- 31.Isenberg HD, editor. Clinical microbiology procedures handbook. Epidemiologic and infection control microbiology. Vol. 3, sect. 13.10.1, 2nd ed. ASM Press, Washington, D.C., 2004.Google Scholar
- 32.Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. In: Sixteenth informational supplement M100-S16. 2006.Google Scholar
- 44.Graindorge A, Menard A, Neto M, Bouvet C, Miollan R, Gaillard S, et al. Epidemiology and molecular characterization of a clone of Burkholderia cenocepacia responsible for nosocomial pulmonary tract infections in a French intensive care unit. Diagn Microbiol Infect Dis. 2010;66:29–40.CrossRefPubMedGoogle Scholar